Skip to main content
CDXS
NASDAQ Life Sciences

Codexis Posts $15.7M Q3 Product Revenue, Narrower $8.1M Net Loss

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$0.995
Mkt Cap
$104.917M
52W Low
$0.9
52W High
$2.98
52W Position info
11% above low
Off High info
67% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

CDXS is trading near its 52-week low of $0.9 (11% above the low).

Summary

Codexis reported Q3 revenue of $19.3 million, with product revenue of $15.74 million, up from the $13.2 million booked in Q2, a net loss of $8.128 million and basic EPS of -$0.08. The operating loss came in at $7.436 million and the pretax loss at $8.119 million. The revenue line is the key read: product sales are the growth engine the company has been leaning on, and this quarter extends the Q2 momentum. The loss is smaller than Q2's $12.0 million net loss, so the burn is trending the right way. The company also reiterated its 2026 revenue guidance. This lands days after the Nov 10 announcement of a $60 million senior secured term loan with Trinity Capital, of which $42.5 million was drawn to retire the Innovatus debt — liquidity is the story alongside the top line.

At the time of this announcement, CDXS was trading at $0.99 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $104.9M. The 52-week trading range was $0.90 to $2.98. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

CDXS - Latest Insights

CDXS
Nov 10, 2026, 6:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.11
Real-time Price: $1.06 info
Change: -$0.050 (-5%) info
Market Cap: $104.917M info
CDXS
Sep 28, 2026, 6:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.44
Real-time Price: $1.06 info
Change: -$0.380 (-26%) info
Market Cap: $104.917M info
CDXS
Aug 11, 2026, 4:21 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $1.51
Real-time Price: $1.06 info
Change: -$0.445 (-30%) info
Market Cap: $104.917M info
CDXS
Aug 11, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.55
Real-time Price: $1.06 info
Change: -$0.490 (-32%) info
Market Cap: $104.917M info
CDXS
Jul 27, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.55
Real-time Price: $1.06 info
Change: -$0.490 (-32%) info
Market Cap: $104.917M info